SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

YARW

Yarrow Bioscience, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 22h ago SEC0001104659-26-127183
Passive stake amendment
Actionable Insight • Neutral

This is a routine passive disclosure by a small fund with no material implications. Monitor for any future conversion to a 13D filing if Nantahala increases its stake above 5% or engages with management.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Nantahala Capital Management filed an amended Schedule 13G disclosing a 0.46% passive stake (39,198 shares) in Yarrow Bioscience as of September 30, 2026. This is a small, routine amendment with no material change from a prior filing; the stake is well below the 5% threshold and represents a negligible position relative to the company's $168M market cap.

Key Financial Metrics

Stake
0.46%
Investor
Nantahala Capital Management, LLC
Investor Type
hedge fund

Key Facts

  • Nantahala Capital Management disclosed beneficial ownership of 39,198 shares of Yarrow Bioscience common stock as of September 30, 2026
  • The stake represents 0.46% of shares outstanding
  • The filing is an amendment to a Schedule 13G, indicating a passive investment intent
  • The filing was made jointly by Nantahala Capital Management, Wilmot B. Harkey, and Daniel Mack
  • No shares are held directly by the reporting persons; all 39,198 shares are held through funds and managed accounts under Nantahala's control

Financial Impact

Stake value approximately $773K based on $168M market cap and 9.44M shares outstanding (from prior 13G context); negligible relative to company size

Risk Factors

  • No material risks identified from this filing; the stake is well below 5% and passive

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001104659-26-127183
Document: 0001104659-26-127183-index.html0001104659-26-127183
Document: 0001104659-26-127183.txt0001104659-26-127183

Track record

13 reports on YARW

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 17, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $14.20 Now $14.27 +0.49% settles Dec 16
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
  4. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
  5. Nov 16, 20261d ago SC 13G/A Neutral 3/10 Entry $15.44 Now $14.27 −7.58% settles Dec 15
  6. Nov 16, 20261d ago SC 13G Neutral 3/10 Entry $18.20 Now $14.27 −21.59% settles Dec 15
  7. Nov 16, 20261d ago SC 13G/A Neutral 3/10 Entry $18.03 Now $14.27 −20.85% settles Dec 15
  8. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Viewing Entry $17.35 Now $14.27 −17.75% settles Dec 15
  9. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $18.03 Now $14.27 −20.85% settles Dec 15
  10. Nov 12, 20265d ago 8-K Neutral 4/10 Entry $19.63 Now $14.27 −27.31% settles Dec 11
Showing 10 of 13

US Market Status

Market Open · Closes in 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026